First calculation
Separate the medicine from the monitored treatment visit.
The number quoted for one part of care may not include the other services required on the treatment date.
SPRAVATO is administered in a certified healthcare setting, and the current prescribing information requires monitoring for at least two hours after each dose. The official coverage guide advises asking whether the medicine uses the medical or pharmacy benefit and whether the treatment visit uses the medical plan or a behavioral-health benefit. That split can change the network, deductible, claim, and cost questions you need answered.
Medicine
Benefit type, specialty-pharmacy or medical-claim route, deductible, copay, coinsurance, and plan quantity rules.
Administration and observation
Treatment-day clinical services, required monitoring, and any professional or observation charge.
Evaluation and follow-up
Psychiatric assessment, records review, outcome measurement, medication management, and later visits.
Facility and network
The treatment location, prescriber, facility, specialty pharmacy, and billing entity may not share one network status.
Treatment frequency
Total cost changes with the prescribed schedule, response, maintenance plan, and services billed at each visit.
Practical costs
Transportation, time away from work, caregiver support, and appointment or cancellation terms.
Coverage does not mean one universal rule
Current insurer policies show why a generic checklist can mislead.
Two current national policies both use prior authorization, but their documentation and timing are not identical.
The examples below were checked August 12, 2026. They are not a shortcut for the member's current plan document, and they do not establish whether a particular person qualifies.
| Current policy example | What the policy illustrates | What the member still must verify |
|---|---|---|
| Cigna national formulary policy | For initial treatment-resistant-depression therapy, the policy lists diagnosis, documented antidepressant history, safety considerations, and specialist involvement; its stated approval period is six months. | The exact benefit plan, applicable policy version, required records, network, benefit route, authorization decision, and personal cost. |
| UnitedHealthcare commercial policy | The July 2026 policy lists diagnosis, baseline symptom measurement, documented treatment history, REMS-setting certification, and psychiatrist involvement; its stated authorization period is twelve months. | The exact member plan, state or employer variation, current criteria, reauthorization rules, network, claim route, and cost share. |
Benefits call script
Ask for eight answers—not one yes or no.
Record the date, representative, reference number, exact plan, and exact treatment center for every answer.
- Is the SPRAVATO medicine processed under my medical benefit or pharmacy benefit?
- Are the treatment visit, administration, and required observation billed separately?
- Is the exact treatment center, prescriber, facility, and billing entity in network?
- Is prior authorization required, and which current policy or criteria apply to my plan?
- Which records must the treating clinician submit, and who owns the next action?
- What deductible, copay, coinsurance, or other cost share applies to each billable part?
- Does my estimate include the medicine, observation, evaluation, facility, and follow-up?
- If coverage is denied or delayed, what is the written reason and appeal deadline?
Ask the treatment center for the names of every organization that may bill the plan before calling the insurer. A center can be certified under the SPRAVATO REMS and still be out of network for a particular member or service.
Printable real-cost worksheet
Build the estimate from the billable parts.
Keep completed health and insurance details with the insurer and care team. Advanced Depression Care does not collect them through this guide.
Health plan, plan type, and member-services number:
Exact treatment center, location, prescriber, facility, and billing entity:
Medicine benefit route and in-network status:
Administration and observation benefit route and in-network status:
Evaluation, facility, and follow-up charges:
Prior-authorization policy, required records, owner, and reference number:
Deductible remaining for each applicable benefit:
Copay or coinsurance for medicine:
Copay or coinsurance for visit, observation, and facility:
Estimated number of visits in the current treatment plan:
Manufacturer or other assistance checked, eligibility, limits, and expiration:
Written total estimate and what could cause it to change:
Denial reason, appeal route, deadline, and next owner, if applicable:
Savings programs
Apply assistance to the correct part of the cost.
The manufacturer currently separates medicine assistance from an observation rebate, and each program has its own rules and limits.
SPRAVATO withMe currently states that eligible commercially insured patients may pay as little as $10 per treatment for the medicine, subject to program requirements, quantity and annual limits, and terms that may change. That medicine program does not cover observation. A separate Observation Rebate Program currently says eligible patients may pay $0 after rebate for observation, with an annual limit and state exclusions. Government coverage and uninsured or underinsured patients have different support routes. Confirm the current terms directly and do not treat an assistance estimate as insurance approval.
When authorization is denied
Turn the denial into a dated action plan.
A written reason tells the treating team whether the next step is a missing record, a policy criterion, a network issue, a benefit-routing problem, or an appeal.
- 1
Get the decision in writing
Record the reason, policy, date, reference number, and appeal instructions.
- 2
Match the reason to the responsible owner
The treating clinician addresses medical documentation; the coverage or billing team addresses benefit, claim, and network details.
- 3
Protect the deadline
Confirm who will submit the internal appeal, what additional information is needed, and the due date.
- 4
Ask about independent review
HealthCare.gov explains that external review may be available after an internal appeal, with an expedited route in qualifying urgent situations.
- 5
Keep clinical care separate from the insurance decision
Discuss safe interim care and appropriate alternatives with the clinician responsible for treatment.
Clinical and insurance limits
Coverage is not a treatment recommendation.
Insurance approval does not establish that SPRAVATO is appropriate for a particular person, and a denial does not independently decide the best clinical plan.
The current prescribing information includes boxed warnings and requires administration in a certified setting with post-dose monitoring. A qualified prescriber must assess diagnosis, treatment history, current medicines, risks, safety needs, and whether the treatment setting and follow-up plan fit the person.
Common cost and coverage questions
SPRAVATO insurance answers to verify
How much does SPRAVATO cost with insurance?
There is no reliable nationwide insured price. Your amount can depend on whether the medicine and clinical services use the medical or pharmacy benefit, the deductible, copay or coinsurance, network, treatment schedule, facility charges, and any assistance for which you qualify. Ask the insurer and treatment center to verify each billable part in writing.
Is SPRAVATO covered by insurance?
Many health plans have a coverage pathway for eligible members, but coverage is not automatic and plan rules differ. The plan may require prior authorization, clinical documentation, a certified treatment setting, network participation, and other current criteria.
Does insurance cover the two-hour observation period?
Coverage and billing vary. Ask whether observation, administration, or facility services are separate from the medicine, which benefit processes each service, whether every billing entity is in network, and what cost share applies.
Does SPRAVATO require prior authorization?
Many plans use prior authorization, but the criteria and approval period can differ. The treating center should check the current policy for the exact plan rather than relying on a generic checklist or another insurer's rules.
Does prior authorization guarantee payment?
No. HealthCare.gov explains that preauthorization is not a promise that a plan will cover the cost. Network, eligibility, benefit terms, coding, site of care, and the services actually billed can still affect the final claim and patient responsibility.
What if insurance denies SPRAVATO?
Ask for the written reason, the policy criteria used, the internal-appeal instructions and deadline, and whether external review is available. Connect the next action to the treating clinician or coverage team, and discuss clinically appropriate care while the decision is being reviewed.
Can the SPRAVATO withMe program lower the cost?
The manufacturer currently says eligible commercially insured patients may pay as little as $10 per treatment for the medicine, subject to program requirements, limits, and changeable terms. That medicine program does not cover treatment observation; a separate observation rebate has its own eligibility and limits. Verify current terms directly before relying on either program.
Primary and official sources
Check the current label, program terms, and plan policy.
- DailyMed: Current SPRAVATO prescribing information (updated March 13, 2026)
- SPRAVATO: Insurance coverage questions
- SPRAVATO withMe: Cost support and program terms
- FDA: SPRAVATO REMS
- Cigna: 2026 SPRAVATO prior-authorization policy
- UnitedHealthcare: 2026 SPRAVATO prior-authorization policy
- HealthCare.gov: What preauthorization does and does not mean
- HealthCare.gov: Appealing a health-plan decision
Official labeling establishes the approved product and safety pathway; it does not establish personal eligibility, coverage, network, or cost. Manufacturer support terms and insurer policies can change. Verify the exact plan and date directly before making a financial decision.
